✦ LIBER ✦

Rituximab, Dexamethasone, Cytarabine, and Oxaliplatin (R-DHAX) Is an Effective and Safe Salvage Regimen in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

✍ Scribed by Julie Lignon; David Sibon; Isabelle Madelaine; Pauline Brice; Patricia Franchi; Josette Briere; Nicolas Mounier; Christian Gisselbrecht; Pierre Faure; Catherine Thieblemont

Book ID: 119936260
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 144 KB
Volume: 10
Category: Article
ISSN: 2152-2650
DOI: 10.3816/clml.2010.n.055

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxaliplatin-based chemotherapy (dexameth

Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin) ± rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma

✍ Luigi Rigacci; Alberto Fabbri; Benedetta Puccini; Ida Chitarrelli; Annalisa Chia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

An effective salvage treatment using ifo

An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma

✍ Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayash 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 234 KB

Phase II study of a salvage regimen usin

Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma

✍ Yasuhiro Oki; Michinori Ogura; Harumi Kato; Ako Kikuchi; Hirofumi Taji; Yoshitoy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Cladribine combined with rituximab (R-2-

Cladribine combined with rituximab (R-2-CdA) therapy is an effective salvage therapy in relapsed or refractory indolent B-cell non-Hodgkin lymphoma

✍ Hirokazu Nagai; Michinori Ogura; Shigeru Kusumoto; Naoto Takahashi; Motoko Yamag 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Erratum to: An effective salvage treatme

Erratum to: An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma

✍ Katsuhiro Miura; Kazuhiro Takei; Sumiko Kobayashi; Satomi Kiso; Yukio Hirabayash 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 86 KB

Gemcitabine, Busulfan and Melphalan (Gem

Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) Is a New High-Dose Chemotherapy (HDC) Regimen with High Activity in Refractory or Poor-Risk Relapsed Non-Hodgkin'S Lymphoma (NHL) Patients Receiving an Autologous Stem-Cell Transplant (ASCT)

✍ Y. Nieto; R.B. Jones; U. Popat; B. Andersson; B. Valdez; P. Thall; E.J. Shpall; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB